Seth Thompson

Seth Thompson has a diverse work experience in the medical and pharmaceutical industry. Seth currently serves as the Head of Clinical Supply at the Bill & Melinda Gates Medical Research Institute since April 2022. Prior to their current role, they were the Director of Clinical Supply Chain at Cogent Biosciences from January 2021 to March 2022. From March 2012 to December 2020, they worked as the Director of Clinical Reach at Zuellig Pharma. Seth also held the position of Manager of Investigational Supply at Takeda Oncology from October 2006 to February 2012. Additionally, they worked as the Clinical Supplies Leader at Johnson & Johnson from August 2005 to September 2006 and as a Clinical Supplies Vendor Manager at Pfizer from April 2001 to July 2005.

Seth Thompson's education history showcases a diverse range of academic interests. Prior to 2020, Seth pursued a Master of Liberal Arts (ALM) degree in Biological Sciences from Harvard University.

In 2014, Seth had completed an Executive Education program in Strategic Management from the NUS Business School at the National University of Singapore.

Prior to these achievements, Seth attended the University of Connecticut, where they pursued a Bachelor of Science (BS) degree. While there, Seth focused their studies on Natural Sciences, Architecture, and Business. The exact duration of Seth's time at the University of Connecticut is not provided.